1. Home
  2. GRBK vs AMRX Comparison

GRBK vs AMRX Comparison

Compare GRBK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • AMRX
  • Stock Information
  • Founded
  • GRBK N/A
  • AMRX 2002
  • Country
  • GRBK United States
  • AMRX United States
  • Employees
  • GRBK N/A
  • AMRX N/A
  • Industry
  • GRBK Homebuilding
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRBK Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • GRBK Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • GRBK 3.1B
  • AMRX 2.9B
  • IPO Year
  • GRBK N/A
  • AMRX N/A
  • Fundamental
  • Price
  • GRBK $69.83
  • AMRX $9.56
  • Analyst Decision
  • GRBK Buy
  • AMRX Strong Buy
  • Analyst Count
  • GRBK 2
  • AMRX 4
  • Target Price
  • GRBK $71.00
  • AMRX $11.50
  • AVG Volume (30 Days)
  • GRBK 229.6K
  • AMRX 1.6M
  • Earning Date
  • GRBK 10-29-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • GRBK N/A
  • AMRX N/A
  • EPS Growth
  • GRBK 7.68
  • AMRX N/A
  • EPS
  • GRBK 7.83
  • AMRX 0.01
  • Revenue
  • GRBK $2,137,742,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • GRBK N/A
  • AMRX $9.56
  • Revenue Next Year
  • GRBK $6.60
  • AMRX $6.27
  • P/E Ratio
  • GRBK $8.92
  • AMRX $875.66
  • Revenue Growth
  • GRBK 13.87
  • AMRX 9.81
  • 52 Week Low
  • GRBK $50.57
  • AMRX $6.69
  • 52 Week High
  • GRBK $84.66
  • AMRX $9.79
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 58.14
  • AMRX 68.42
  • Support Level
  • GRBK $68.72
  • AMRX $9.20
  • Resistance Level
  • GRBK $71.75
  • AMRX $9.79
  • Average True Range (ATR)
  • GRBK 1.95
  • AMRX 0.25
  • MACD
  • GRBK 0.05
  • AMRX 0.01
  • Stochastic Oscillator
  • GRBK 72.69
  • AMRX 76.29

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: